1. [A case of del(16)(q22) in a patient with acute myeloid leukemia with complex karyotype].
- Author
-
Kim M, Lee JW, Lee JK, Hong YJ, Hong SI, Kang HJ, Cho EH, and Chang YH
- Subjects
- Antimetabolites, Antineoplastic therapeutic use, Cytarabine therapeutic use, Daunorubicin therapeutic use, Drug Therapy, Combination, Humans, In Situ Hybridization, Fluorescence, Karyotyping, Leukemia, Myeloid, Acute diagnosis, Leukemia, Myeloid, Acute drug therapy, Male, Middle Aged, Monocyte-Macrophage Precursor Cells cytology, Prognosis, Chromosome Deletion, Chromosomes, Human, Pair 16, Leukemia, Myeloid, Acute genetics
- Abstract
Inversion of chromosome 16 [inv(16)(p13.1q22)] and t(16;16)(p13.1;q22) are associated with acute myelomonocytic leukemia (AMML) with eosinophilia and a favorable prognosis. On the other hand, patients with del(16)(q22) usually present with MDS or chronic myelomonocytic leukemia (CMML), which can evolve to AMML without eosinophilia, and this chromosomal aberration is associated with older age, a complex karyotype, and a poor prognosis. We report a case of AML with del(16)(q22) which showed a complex karyotype, absence of eosinophilia in bone marrow study and a poor response to chemotherapy.
- Published
- 2010
- Full Text
- View/download PDF